These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6034391)

  • 21. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MONOAMINE-OXIDASE INHIBITOR REACTIONS SIMULATING PHENOCHROMOCYTOMA ATTACKS.
    PLASS HF
    Ann Intern Med; 1964 Nov; 61():924-7. PubMed ID: 14233813
    [No Abstract]   [Full Text] [Related]  

  • 24. Mysterious MAOI hypertensive episodes.
    Linet LS
    J Clin Psychiatry; 1986 Nov; 47(11):563-5. PubMed ID: 3095312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.
    Abrams JH; Schulman P; White WB
    N Engl J Med; 1985 Jul; 313(1):52. PubMed ID: 4000229
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG; Quitkin FM; McGrath P; Harrison W; Tricamo E
    J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT.
    TSAI TH; FLEMING WW
    Biochem Pharmacol; 1965 Mar; 14():369-71. PubMed ID: 14314337
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction between the irreversible MAOIs and certain foods.
    Beavis D
    Aust Fam Physician; 1999 Jul; 28(7):650, 652. PubMed ID: 10431417
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of cocaine abuse with monoamine oxidase inhibitors.
    Brewer C
    Br J Psychiatry; 1993 Dec; 163():815-6. PubMed ID: 8306127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment: Switching MAO inhibitors.
    True BL; Alexander B; Carter BL
    Drug Intell Clin Pharm; 1986 May; 20(5):384-5. PubMed ID: 3709351
    [No Abstract]   [Full Text] [Related]  

  • 32. Revisiting the "cheese reaction": more than just a hypertensive crisis?
    Alkhouli M; Mathur M; Patil P
    J Clin Psychopharmacol; 2014 Oct; 34(5):665-7. PubMed ID: 25118080
    [No Abstract]   [Full Text] [Related]  

  • 33. HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS.
    BLACKWELL B
    Lancet; 1963 Oct; 2(7313):849-50. PubMed ID: 14056007
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversibility of MAO inhibition.
    Baxter LR
    J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
    [No Abstract]   [Full Text] [Related]  

  • 35. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
    Pope HG; Jonas JM; Hudson JI; Kafka MP
    Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors.
    Johnson WC
    Dis Nerv Syst; 1975 Sep; 36(9):521-5. PubMed ID: 1175468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.